The biggest and most comprehensive analysis of glucagon-like peptide-1 (GLP-1) receptor agonists on kidney and cardiovascular outcomes shows they have significant benefits in people with and without diabetes.
source https://www.sciencedaily.com/releases/2024/11/241125195050.htm
The COVID‑19 pandemic exposed the load mothers carry—a burden that's still
being ignored today
-
The COVID-19 pandemic exacerbated and brought into focus the ongoing
disproportionate burden on mothers when it comes to household logistics,
child care an...
2 days ago
No comments:
Post a Comment